Corrigendum to 'Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation' [Biology of Blood and Marrow Transplantation 26/10 (2020) 1876-1885]. Transplant Cell Ther 2022 Oct;28(10):717
Date
10/07/2022Pubmed ID
36202527DOI
10.1016/j.jtct.2021.01.005Scopus ID
2-s2.0-85101258094 (requires institutional sign-in at Scopus site)Author List
Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Rizzo JD, Runaas L, Saber W, Shah NN, Shaw BE, Horowitz MM, Hari PN, Hamadani MAuthors
Sameem Abedin MD Associate Professor in the Medicine department at Medical College of WisconsinAnita D'Souza MD Professor in the Medicine department at Medical College of Wisconsin
Binod Dhakal MBBS, MD Associate Professor in the Medicine department at Medical College of Wisconsin
Mehdi Hamadani MBBS Professor in the Medicine department at Medical College of Wisconsin
Parameswaran Hari MD Adjunct Professor in the Medicine department at Medical College of Wisconsin
Mary M. Horowitz MS, MD Adjunct Professor in the Medicine department at Medical College of Wisconsin
J. Douglas Rizzo MS, MD Director, Center Associate Director, Professor in the Medicine department at Medical College of Wisconsin
Wael Saber MBBS, MS Professor in the Medicine department at Medical College of Wisconsin
Nirav N. Shah MD Professor in the Medicine department at Medical College of Wisconsin
Bronwen E. Shaw PhD, MD Center Director, Professor in the Medicine department at Medical College of Wisconsin
Alexis M. Visotcky Biostatistician III in the Data Science Institute department at Medical College of Wisconsin
